Search

Search Results
Results 12161 - 12170 of 12173 for Placebo
  • Kliovance
    Drug - 18 Dec 2025
    Consumer Medicine Information (CMI) about Kliovance intended for persons living in Australia.
  • Kliogest
    Drug - 18 Dec 2025
    Consumer Medicine Information (CMI) about Kliogest intended for persons living in Australia.
  • Reminyl
    Drug - 14 Nov 2025
    Consumer Medicine Information (CMI) about Reminyl intended for persons living in Australia.
  • Galantyl
    Drug - 24 Sep 2025
    Consumer Medicine Information (CMI) about Galantyl intended for persons living in Australia.
  • Zeldox Capsules
    Drug - 1 May 2025
    Consumer Medicine Information (CMI) about Zeldox Capsules intended for persons living in Australia.
  • Allertine
    Drug - 10 Mar 2025
    Consumer Medicine Information (CMI) about Allertine intended for persons living in Australia.
  • Xtandi
    Drug - 24 Feb 2025
    Consumer Medicine Information (CMI) about Xtandi intended for persons living in Australia.
  • Pfizer announces that 14 abstracts for tofacitinib to be presented at ACR/ARHP annual meeting
    News - 18 Sep 2012
    Pfizer Inc. announced today that 14 abstracts for tofacitinib, an investigational oral Janus kinase (JAK) inhibitor for the treatment of adults with moderate-to-severe active rheumatoid arthritis...
  • Alnylam first quarter revenues decrease to $20.6 million
    News - 4 May 2012
    Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today reported its consolidated financial results for the first quarter 2012, and company highlights.
  • Trisequens
    Drug - 19 Dec 2025
    Consumer Medicine Information (CMI) about Trisequens intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback